WEST PHARMACEUTICAL SERVICES (WST) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:WST • US9553061055

244.993 USD
+1.43 (+0.59%)
Last: Feb 11, 2026, 09:40 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Taking everything into account, WST scores 7 out of 10 in our fundamental rating. WST was compared to 58 industry peers in the Life Sciences Tools & Services industry. WST gets an excellent profitability rating and is at the same time showing great financial health properties. WST has a decent growth rate and is not valued too expensively. These ratings would make WST suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • WST had positive earnings in the past year.
  • In the past year WST had a positive cash flow from operations.
  • In the past 5 years WST has always been profitable.
  • In the past 5 years WST always reported a positive cash flow from operatings.
WST Yearly Net Income VS EBIT VS OCF VS FCFWST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • WST has a better Return On Assets (11.98%) than 93.10% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.11%, WST belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 14.78%, WST belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for WST is above the industry average of 13.21%.
Industry RankSector Rank
ROA 11.98%
ROE 16.11%
ROIC 14.78%
ROA(3y)15.07%
ROA(5y)15.52%
ROE(3y)20.26%
ROE(5y)21.56%
ROIC(3y)17.99%
ROIC(5y)18.35%
WST Yearly ROA, ROE, ROICWST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.29%, WST belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
  • WST's Profit Margin has improved in the last couple of years.
  • WST has a Operating Margin of 20.71%. This is amongst the best in the industry. WST outperforms 87.93% of its industry peers.
  • WST's Operating Margin has improved in the last couple of years.
  • The Gross Margin of WST (35.58%) is worse than 60.34% of its industry peers.
  • WST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.71%
PM (TTM) 16.29%
GM 35.58%
OM growth 3Y-8.66%
OM growth 5Y4.7%
PM growth 3Y-10.02%
PM growth 5Y5.33%
GM growth 3Y-6.03%
GM growth 5Y0.95%
WST Yearly Profit, Operating, Gross MarginsWST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • WST has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, WST has less shares outstanding
  • WST has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for WST is higher compared to a year ago.
WST Yearly Shares OutstandingWST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
WST Yearly Total Debt VS Total AssetsWST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 13.01 indicates that WST is not in any danger for bankruptcy at the moment.
  • WST's Altman-Z score of 13.01 is amongst the best of the industry. WST outperforms 96.55% of its industry peers.
  • WST has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
  • The Debt to FCF ratio of WST (0.55) is better than 91.38% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that WST is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.07, WST is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.55
Altman-Z 13.01
ROIC/WACC1.35
WACC10.97%
WST Yearly LT Debt VS Equity VS FCFWST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • WST has a Current Ratio of 2.87. This indicates that WST is financially healthy and has no problem in meeting its short term obligations.
  • WST's Current ratio of 2.87 is in line compared to the rest of the industry. WST outperforms 50.00% of its industry peers.
  • A Quick Ratio of 2.18 indicates that WST has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.18, WST is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.18
WST Yearly Current Assets VS Current LiabilitesWST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.59% over the past year.
  • WST shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.81% yearly.
  • WST shows a small growth in Revenue. In the last year, the Revenue has grown by 4.92%.
  • WST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.48% yearly.
EPS 1Y (TTM)4.59%
EPS 3Y-7.79%
EPS 5Y15.81%
EPS Q2Q%5.95%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y0.72%
Revenue growth 5Y9.48%
Sales Q2Q%7.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.12% on average over the next years. This is quite good.
  • Based on estimates for the next years, WST will show a small growth in Revenue. The Revenue will grow by 6.45% on average per year.
EPS Next Y6.29%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
EPS Next 5Y10.12%
Revenue Next Year6.25%
Revenue Next 2Y6.26%
Revenue Next 3Y6.44%
Revenue Next 5Y6.45%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WST Yearly Revenue VS EstimatesWST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
WST Yearly EPS VS EstimatesWST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • WST is valuated quite expensively with a Price/Earnings ratio of 34.65.
  • The rest of the industry has a similar Price/Earnings ratio as WST.
  • WST is valuated rather expensively when we compare the Price/Earnings ratio to 28.03, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 31.21, WST can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of WST indicates a somewhat cheap valuation: WST is cheaper than 60.34% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, WST is valued at the same level.
Industry RankSector Rank
PE 34.65
Fwd PE 31.21
WST Price Earnings VS Forward Price EarningsWST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, WST is valued a bit cheaper than the industry average as 67.24% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, WST is valued a bit cheaper than 62.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.49
EV/EBITDA 21.64
WST Per share dataWST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WST does not grow enough to justify the current Price/Earnings ratio.
  • WST has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.51
PEG (5Y)2.19
EPS Next 2Y7.84%
EPS Next 3Y9.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, WST is not a good candidate for dividend investing.
  • WST's Dividend Yield is rather good when compared to the industry average which is at 0.09. WST pays more dividend than 86.21% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, WST's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of WST has a limited annual growth rate of 5.90%.
  • WST has paid a dividend for at least 10 years, which is a reliable track record.
  • WST has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.9%
Div Incr Years32
Div Non Decr Years34
WST Yearly Dividends per shareWST Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • WST pays out 12.34% of its income as dividend. This is a sustainable payout ratio.
  • WST's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12.34%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
WST Yearly Income VS Free CF VS DividendWST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
WST Dividend Payout.WST Dividend Payout, showing the Payout Ratio.WST Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

WEST PHARMACEUTICAL SERVICES

NYSE:WST (2/11/2026, 9:40:00 AM)

244.993

+1.43 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-23
Earnings (Next)02-12
Inst Owners97.92%
Inst Owner Change-1.93%
Ins Owners0.33%
Ins Owner Change0%
Market Cap17.62B
Revenue(TTM)3.02B
Net Income(TTM)491.70M
Analysts80.91
Price Target353.41 (44.25%)
Short Float %2.68%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.81
Dividend Growth(5Y)5.9%
DP12.34%
Div Incr Years32
Div Non Decr Years34
Ex-Date01-28
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.04%
Min EPS beat(2)15.4%
Max EPS beat(2)20.68%
EPS beat(4)4
Avg EPS beat(4)14.32%
Min EPS beat(4)4.78%
Max EPS beat(4)20.68%
EPS beat(8)7
Avg EPS beat(8)11.13%
EPS beat(12)11
Avg EPS beat(12)13.12%
EPS beat(16)14
Avg EPS beat(16)10.97%
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)1.1%
Max Revenue beat(2)4.33%
Revenue beat(4)4
Avg Revenue beat(4)1.58%
Min Revenue beat(4)0.12%
Max Revenue beat(4)4.33%
Revenue beat(8)6
Avg Revenue beat(8)0.82%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)0.44%
PT rev (1m)-0.18%
PT rev (3m)0.33%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)-0.19%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 34.65
Fwd PE 31.21
P/S 5.84
P/FCF 46.49
P/OCF 25.4
P/B 5.78
P/tB 6.01
EV/EBITDA 21.64
EPS(TTM)7.07
EY2.89%
EPS(NY)7.85
Fwd EY3.2%
FCF(TTM)5.27
FCFY2.15%
OCF(TTM)9.64
OCFY3.94%
SpS41.95
BVpS42.42
TBVpS40.76
PEG (NY)5.51
PEG (5Y)2.19
Graham Number82.14
Profitability
Industry RankSector Rank
ROA 11.98%
ROE 16.11%
ROCE 18.01%
ROIC 14.78%
ROICexc 18.05%
ROICexgc 18.84%
OM 20.71%
PM (TTM) 16.29%
GM 35.58%
FCFM 12.56%
ROA(3y)15.07%
ROA(5y)15.52%
ROE(3y)20.26%
ROE(5y)21.56%
ROIC(3y)17.99%
ROIC(5y)18.35%
ROICexc(3y)23.92%
ROICexc(5y)24.8%
ROICexgc(3y)25.26%
ROICexgc(5y)26.44%
ROCE(3y)21.92%
ROCE(5y)22.37%
ROICexgc growth 3Y-17.09%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-16.41%
ROICexc growth 5Y3.44%
OM growth 3Y-8.66%
OM growth 5Y4.7%
PM growth 3Y-10.02%
PM growth 5Y5.33%
GM growth 3Y-6.03%
GM growth 5Y0.95%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.55
Debt/EBITDA 0.26
Cap/Depr 190.61%
Cap/Sales 10.43%
Interest Coverage 250
Cash Conversion 87.8%
Profit Quality 77.1%
Current Ratio 2.87
Quick Ratio 2.18
Altman-Z 13.01
F-Score6
WACC10.97%
ROIC/WACC1.35
Cap/Depr(3y)247.41%
Cap/Depr(5y)221.86%
Cap/Sales(3y)11.72%
Cap/Sales(5y)10.45%
Profit Quality(3y)66.98%
Profit Quality(5y)67.4%
High Growth Momentum
Growth
EPS 1Y (TTM)4.59%
EPS 3Y-7.79%
EPS 5Y15.81%
EPS Q2Q%5.95%
EPS Next Y6.29%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
EPS Next 5Y10.12%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y0.72%
Revenue growth 5Y9.48%
Sales Q2Q%7.73%
Revenue Next Year6.25%
Revenue Next 2Y6.26%
Revenue Next 3Y6.44%
Revenue Next 5Y6.45%
EBIT growth 1Y6.71%
EBIT growth 3Y-8.01%
EBIT growth 5Y14.63%
EBIT Next Year37.43%
EBIT Next 3Y18.61%
EBIT Next 5Y15.08%
FCF growth 1Y-9.74%
FCF growth 3Y-5.79%
FCF growth 5Y2.8%
OCF growth 1Y-9.68%
OCF growth 3Y3.81%
OCF growth 5Y12.22%

WEST PHARMACEUTICAL SERVICES / WST FAQ

What is the fundamental rating for WST stock?

ChartMill assigns a fundamental rating of 7 / 10 to WST.


What is the valuation status for WST stock?

ChartMill assigns a valuation rating of 4 / 10 to WEST PHARMACEUTICAL SERVICES (WST). This can be considered as Fairly Valued.


Can you provide the profitability details for WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (WST) has a profitability rating of 8 / 10.


Can you provide the financial health for WST stock?

The financial health rating of WEST PHARMACEUTICAL SERVICES (WST) is 8 / 10.


How sustainable is the dividend of WEST PHARMACEUTICAL SERVICES (WST) stock?

The dividend rating of WEST PHARMACEUTICAL SERVICES (WST) is 6 / 10 and the dividend payout ratio is 12.34%.